Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-03

Clinical Trial Update: Evaluation of Therapeutic Strategy to Prevent Crohn's Disease Endoscopic poSToperatIve recurreNce Based on earlY Dosage of Faecal Calprotectin [NA]

View source ↗

Summary

A clinical trial is evaluating whether an early fecal calprotectin-guided strategy can prevent endoscopic postoperative recurrence of Crohn's disease after ileo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Crohn Disease (CD), Ileocolic Resection | NA | Status: RECRUITING